Pathway Bioventures
Overview
Pathway Bioventures is a venture capital firm focusing on seed-stage investments in the life sciences sector. The company targets next-generation therapeutics, medical devices, and diagnostics, seeking to support exceptional teams that utilize innovative biotechnology to tackle significant unmet medical needs. By concentrating on advancements at the forefront of biology and engineering, Pathway Bioventures aims to foster the development of transformative healthcare solutions.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Crossbow Therapeutics | Jul 2023 | Series A | - |
| Afference | Oct 2024 | Seed | Co-investor |
| miRecule, Inc. | May 2021 | Seed | Co-investor |
| Ascidian Therapeutics | Oct 2022 | Series A | - |
| BioGraph 55 | Jun 2024 | Series B | Co-investor |
For institutional investors. Book with your work email.
Key People
Daniel Jacobs
Founder & Managing Partner
Matt Martin
Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Pathway Bioventures based?
Pathway Bioventures is headquartered in Chicago, Illinois, United States.
When was Pathway Bioventures founded?
Pathway Bioventures was founded in 2018.
How many portfolio companies does Pathway Bioventures have?
Pathway Bioventures has 12 portfolio companies in Caplight's dataset.
What are some companies in Pathway Bioventures's portfolio?
Portfolio companies visible on Caplight include Crossbow Therapeutics, Afference, miRecule, Inc., Ascidian Therapeutics, BioGraph 55.
What was Pathway Bioventures's most recent investment shown here?
Pathway Bioventures's most recent investment in this portfolio sample was in Afference in 2024.
What sectors does Pathway Bioventures focus on?
Pathway Bioventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences.
What company stages does Pathway Bioventures focus on?
Pathway Bioventures typically invests at the Early stage.
What is Pathway Bioventures's AUM?
Pathway Bioventures's assets under management are estimated between $0.0 and $50.0M.